The Valley Desk

NCT07198074 · Interventional trial

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Overall registry status Recruiting

Phase 3

Conditions Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov